Search

everythinglearnresearchcommunity

for

Search:↓

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

Epidermal stem cells are diverse and vary in activity, playing key roles in skin maintenance and repair.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Human hair has a protective lipid layer that can be damaged by moisture and treatments, affecting hair growth and health.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Women with hair loss have more androgen receptors in certain hair follicles.

Certain skin cells near the base of hair muscles may help renew and stabilize skin, possibly affecting skin disorder understanding.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Hair follicles can regrow in wounded adult mouse skin using a process like embryo development.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

The document concludes that the hair cycle is a complex process involving growth, regression, and rest phases, regulated by various molecular signals.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.